These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
180 related articles for article (PubMed ID: 21967037)
1. Involvement of hippocampal phosphatidylethanolamine-binding protein in morphine dependence and withdrawal. Wei QH; Wu N; Bian JM; Chen Y; Su RB; Li J Addict Biol; 2013 Mar; 18(2):230-40. PubMed ID: 21967037 [TBL] [Abstract][Full Text] [Related]
2. Overexpression of hippocampal cholinergic neurostimulating peptide in heterozygous transgenic mice increases the amount of ChAT in the medial septal nucleus. Uematsu N; Matsukawa N; Kanamori T; Arai Y; Sagisaka T; Toyoda T; Yoshida M; Ojika K Brain Res; 2009 Dec; 1305():150-7. PubMed ID: 19815004 [TBL] [Abstract][Full Text] [Related]
3. Decreased phosphatidylethanolamine binding protein expression correlates with Abeta accumulation in the Tg2576 mouse model of Alzheimer's disease. George AJ; Holsinger RM; McLean CA; Tan SS; Scott HS; Cardamone T; Cappai R; Masters CL; Li QX Neurobiol Aging; 2006 Apr; 27(4):614-23. PubMed ID: 15941609 [TBL] [Abstract][Full Text] [Related]
4. Directed neural lineage differentiation of adult hippocampal progenitor cells via modulation of hippocampal cholinergic neurostimulating peptide precursor expression. Sagisaka T; Matsukawa N; Toyoda T; Uematsu N; Kanamori T; Wake H; Borlongan CV; Ojika K Brain Res; 2010 Apr; 1327():107-17. PubMed ID: 20206149 [TBL] [Abstract][Full Text] [Related]
5. Suppressed phosphorylation of collapsin response mediator protein-2 in the hippocampus of HCNP precursor transgenic mice. Kanamori T; Matsukawa N; Kobayashi H; Uematsu N; Sagisaka T; Toyoda T; Kato D; Oikawa S; Ojika K Brain Res; 2010 Oct; 1355():180-8. PubMed ID: 20682295 [TBL] [Abstract][Full Text] [Related]
6. Decreased hippocampal cholinergic neurostimulating peptide precursor protein associated with stress exposure in rat brain by proteomic analysis. Kim HG; Kim KL J Neurosci Res; 2007 Oct; 85(13):2898-908. PubMed ID: 17628502 [TBL] [Abstract][Full Text] [Related]
8. Reduced Cholinergic Activity in the Hippocampus of Hippocampal Cholinergic Neurostimulating Peptide Precursor Protein Knockout Mice. Madokoro Y; Yoshino Y; Kato D; Sato T; Mizuno M; Kanamori T; Shimazawa M; Hida H; Hara H; Yoshida M; Borlongan CV; Ojika K; Matsukawa N Int J Mol Sci; 2019 Oct; 20(21):. PubMed ID: 31661900 [TBL] [Abstract][Full Text] [Related]
9. Chronic morphine administration induces over-expression of aldolase C with reduction of CREB phosphorylation in the mouse hippocampus. Yang HY; Pu XP Eur J Pharmacol; 2009 May; 609(1-3):51-7. PubMed ID: 19289113 [TBL] [Abstract][Full Text] [Related]
10. Expression of c-Fos in the rat central amygdala accompanies the acquisition but not expression of conditioned place aversion induced by withdrawal from acute morphine dependence. Jin C; Araki H; Nagata M; Shimosaka R; Shibata K; Suemaru K; Kawasaki H; Gomita Y Behav Brain Res; 2005 Jun; 161(1):107-12. PubMed ID: 15904717 [TBL] [Abstract][Full Text] [Related]
11. Morphine dependence is associated with changes in neuropeptide S receptor expression and function in rat brain. Ghazal P; Ciccocioppo R; Ubaldi M Peptides; 2013 Aug; 46():6-12. PubMed ID: 23684726 [TBL] [Abstract][Full Text] [Related]
12. Expression changes of hippocampal energy metabolism enzymes contribute to behavioural abnormalities during chronic morphine treatment. Chen XL; Lu G; Gong YX; Zhao LC; Chen J; Chi ZQ; Yang YM; Chen Z; Li QL; Liu JG Cell Res; 2007 Aug; 17(8):689-700. PubMed ID: 17667915 [TBL] [Abstract][Full Text] [Related]
13. A neuroactive steroid, dehydroepiandrosterone sulfate, prevents the development of morphine dependence and tolerance via c-fos expression linked to the extracellular signal-regulated protein kinase. Ren X; Noda Y; Mamiya T; Nagai T; Nabeshima T Behav Brain Res; 2004 Jul; 152(2):243-50. PubMed ID: 15196791 [TBL] [Abstract][Full Text] [Related]
14. Morphine modulates glutamate release in the hippocampal CA1 area in mice. Guo M; Xu NJ; Li YT; Yang JY; Wu CF; Pei G Neurosci Lett; 2005 Jun 10-17; 381(1-2):12-5. PubMed ID: 15882781 [TBL] [Abstract][Full Text] [Related]
15. HCNP precursor protein transgenic mice display a depressive-like phenotype in old age. Matsukawa N; Furuya Y; Ogura H; Ojika K Brain Res; 2010 Aug; 1349():153-61. PubMed ID: 20599825 [TBL] [Abstract][Full Text] [Related]
16. Extremely low-frequency electromagnetic field exposure during chronic morphine treatment strengthens downregulation of dopamine D2 receptors in rat dorsal hippocampus after morphine withdrawal. Wang X; Liu Y; Lei Y; Zhou D; Fu Y; Che Y; Xu R; Yu H; Hu X; Ma Y Neurosci Lett; 2008 Mar; 433(3):178-82. PubMed ID: 18276072 [TBL] [Abstract][Full Text] [Related]
17. Naloxone-precipitated withdrawal enhances ERK phosphorylation in prefrontal association cortex and accumbens nucleus of morphine-dependent mice. Li T; Hou Y; Cao W; Yan CX; Chen T; Li SB Neurosci Lett; 2010 Jan; 468(3):348-52. PubMed ID: 19922770 [TBL] [Abstract][Full Text] [Related]
18. Disruption of acute opioid dependence by antisense oligodeoxynucleotides targeting neurogranin. Tang L; Shukla PK; Wang ZJ Brain Res; 2007 Apr; 1143():78-82. PubMed ID: 17306231 [TBL] [Abstract][Full Text] [Related]
19. Identification of novel molecular candidates for acute liver failure in plasma of BALB/c murine model. Lv S; Wei L; Wang JH; Wang JY; Liu F J Proteome Res; 2007 Jul; 6(7):2746-52. PubMed ID: 17569552 [TBL] [Abstract][Full Text] [Related]
20. Proteomic analysis of the nucleus accumbens in rhesus monkeys of morphine dependence and withdrawal intervention. Bu Q; Yang Y; Yan G; Hu Z; Hu C; Duan J; Lv L; Zhou J; Zhao J; Shao X; Deng Y; Li Y; Li H; Zhu R; Zhao Y; Cen X J Proteomics; 2012 Feb; 75(4):1330-42. PubMed ID: 22123079 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]